These data have been corroborated by the results of a recent single-center study published by our group in 22 elderly COVID-19 patients [34]—the early administration of high-titer CP was safe and led to a rapid viral clearance, halting the progression of COVID-19 and thus resulting in a survival benefit. Here, CP is linked to COVID-19.